Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Affiris begins clinical testing of Alzheimer’s vaccine
Up to 24 Alzheimer’s patients at the “mild to moderate” disease stage are to be vaccinated, with the aim of this initial phase I trial being to demonstrate
Up to 24 Alzheimer’s patients at the “mild to moderate” disease stage are to be vaccinated, with the aim of this initial phase I trial being to demonstrate
This will allow Cougar to conduct a Phase I clinical trial of CB3304, an orally active inhibitor of microtubule dynamics, for the treatment of relapsed or refractory multiple
First quarter 2009 product revenues consisted of $1.3 million in Celution System sales in Europe and Asia and the recognition of $0.6 million from the installation of a
The positive opinion was reached after the the European Committee for Human Medicinal Products reviewed data from clinical trials in almost 30,000 females, including data from the largest
MD Biosciences said that this rapid response provides researchers with valuable data much more quickly than the traditional collagen-induced arthritis (CIA) model, which can take several weeks or
The company’s worldwide pharmaceutical sales grew 17% in the quarter, while US pharmaceutical sales increased 27%. This was driven by a 50% increase in Humira’s global sales to
First-half profit climbed 24% to 4.9 billion Swiss francs ($4.1 billion) on the back of strong sales of Herceptin, Avastin, and MabThera. On average, analysts had predicted net
This Phase I trial is planned to enroll up to 72 healthy adult volunteers and is primarily intended to evaluate the safety and tolerability of single ascending doses
The submission is based on the 24-week efficacy and safety results of two Phase III randomized, placebo-controlled studies, known as DUET-1 and DUET-2, which studied the use of
The companies plan to sell the insulin to biotechnology and pharmaceutical companies. Terms of the agreement have not been disclosed. Bioprocess scientists have increasingly used insulin to enhance